Publication | Closed Access

Combination of Vaniprevir With Peginterferon and Ribavirin Significantly Increases the Rate of SVR in Treatment-Experienced Patients With Chronic HCV Genotype 1 Infection and Cirrhosis

HepatologyViral HepatitisPathogenesisAntiviral TherapyHepatitisVirologyRibavirin SignificantlyTreatment-experienced PatientsChronic Viral InfectionAntiviral DrugMedicine